China Medical System Holdings Limited (HKG:0867)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
14.24
-0.20 (-1.39%)
Sep 26, 2025, 4:08 PM HKT
-1.39%
Market Cap34.41B
Revenue (ttm)8.61B
Net Income (ttm)1.81B
Shares Out2.42B
EPS (ttm)0.75
PE Ratio19.03
Forward PE17.26
Dividend0.29 (2.05%)
Ex-Dividend DateAug 29, 2025
Volume8,140,000
Average Volume8,290,066
Open14.45
Previous Close14.44
Day's Range14.12 - 14.61
52-Week Range6.71 - 15.63
Beta1.01
RSI48.68
Earnings DateNov 18, 2025

About HKG:0867

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate ... [Read more]

Sector Healthcare
Founded 1995
Employees 6,141
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0867
Full Company Profile

Financial Performance

In 2024, HKG:0867's revenue was 7.47 billion, a decrease of -6.79% compared to the previous year's 8.01 billion. Earnings were 1.62 billion, a decrease of -32.54%.

Financial numbers in CNY Financial Statements

News

Alpha Cognition Announces Partner China Medical System Has NDA Accepted in China for the Review of ZUNVEYL® (Benzgalantamine) for Alzheimer’s Disease

VANCOUVER, British Columbia & DALLAS — Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” [ACI], or the “Company”), a biopharmaceutical company developing novel therapies for debilitating neurodeg...

2 months ago - Financial Post

Alpha Cognition Inks $44 Million Licensing Pact For Its Alzheimer's Drug In China

On Wednesday, Alpha Cognition Inc. (NASDAQ: ACOG) and China Medical System Holdings Limited announced an exclusive licensing agreement for the development, manufacturing, and commercialization of Zun...

9 months ago - Benzinga